An Evaluation of Characteristics of Macular Edema and Best Corrected Visual Acuity in Superotemporal vs Inferotemporal Branch Retinal Vein Occlusions and Assess their Response to Antivascular Endothelial Growth Factors
1Professor and Head, 2Junior Resident, Department of Ophthalmology, Armed Forces Medical College, Pune, Maharashtra 411040, India. 3Associate Professor, Department of Ophthalmology, Command Hospital, Chandimandir Cantonment, Panchkula, Haryana 134114, India. 4Associate Professor, Department of Ophthalmology, INHS Ashvini, Colaba, Mumbai, Maharashtra 400005, India.
Choose an option to locate / access this Article:
90 days Access
Check if you have access
through your login credentials.
PDF
Context: Comparison of characteristics of macular edema and BCVA in STBRVO and ITBRVO and their response to therapy. Settings and design: Institutional setting, Observational study design. Methods and material: 77 eyes of 77 patients of BRVO who met the inclusion criteria were studied for central macular thickness and BCVA both prior to and after Anti-VEGF therapy. Results: Mean BCVA in ST BRVO pre-injection in LogMAR was 1.0093 units and post-injection was 0.50 in cases of IT BRVO it was 0.874 and 0.421 respectively. Commensurate reduction in
CMT occurred in both STBRVO and IT BRVO of 216.87 microns and 232.81 microns. Conclusion: Both are similar in clinical behavior and response to Anti-VEGFs.
Keywords: ST BRVO; IT BRVO; Anti-VEGFs; Central macular thickness.
Author Information Pack
Editorial Board 
Submit article
Editor's selection process
Most popular articles
Archive
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us